Gene Query: ARL8B

Dataset Description Geneva Score
Nrf2 regulated genes in A549 cells 69.19
Identification of Nrf2 regulated genes by RNA sequencing 69.19
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 39.87
Peptidomimetic blockade of MYB in acute myeloid leukemia 39.87
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 39.22
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 31.68
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 30.37
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 29.58
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 29.28
Solid phase chemistry to covalently and reversibly capture thiolated RNA 25.05
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 23.79
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 22.9
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 21.96
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 21.67
Genome wide expression change in LCC2 and MCF-7 cells 20.94
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 20.65
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 20.6
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 20.55
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 20.2
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 19.7
Cleavage Factor Im as a key regulator of 3’ UTR length 19.39
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 18.7
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 17.94
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 17.85
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 17.16
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 16.89
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 16.72
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 16.66
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 16.24
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 16.24
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 15.82
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 15.82
MYCL and EP400 are required for Max and MCPyV mediated gene activation 15.82
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 15.65
Effect of CHKA knockdown on C4-2 cell transcriptome 15.57
METTL3 promotes translation in human cancer cells 15.55
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 15.29
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 14.81
An RNA-centric dissection of host complexes controlling flavivirus infection 14.81
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 14.78
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 14.72
Gene expression changes caused by KRAS in MCF-10A 14.5
RNAseq Analysis in glioblastoma cells treated with Mepazine 14.5
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 14.24
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 14.1
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 14.1
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 14.0
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 13.8
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 13.8
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 13.59
Identification of transcription start sites for human A549 cell line using ReCappable-seq 13.45
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 13.45
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 13.38
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 13.29
Gene expression profiling of leukemia cells following asparagine depletion 13.26
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 13.15
Altering cancer transcriptomes using epigenomic inhibitors 13.15
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 13.15
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 13.1
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 12.79
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 12.78
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 12.76
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 12.57
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 12.45
MYCi975 regulates MYC target genes 12.44
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 12.39
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 12.39
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 12.34
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 12.13
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 12.12
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 11.91
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 11.91
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 11.89
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 11.84
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 11.84
Interaction between mitoNEET and NAF-1 in cancer cells 11.78
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 11.75
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 11.68
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 11.63
Differential analysis of gene regulation at transcript resolution by RNA-Seq 11.59
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 11.59
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 11.54
The comparison of high-throughput single-cell RNA-seq methods 11.51
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 11.4
Splicing and epigenetic factors jointly regulate epidermal differentiation 11.32
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 11.21
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 11.17
KLF6-dependent transcription in renal cancer cells 11.16
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 11.14
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 11.14
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 11.06
Co-transcriptional loading of RNA export factors shapes the human transcriptome 11.06
RNAseq of HEK293 cells after Chtop knockdown 11.06
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 10.93
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 10.9
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 10.77
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 10.7
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 10.67
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 10.62
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 10.58
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 10.43
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 10.43
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 10.41
Transcriptome analysis of kidney organoids 10.37
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 10.35
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 10.35
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 10.33
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 10.3
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 10.28
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 10.24
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 10.23
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 10.21
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 10.02
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 10.01
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 10.01
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 10.01
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 10.0
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 9.91
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 9.91
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 9.89
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 9.78
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 9.78
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 9.72
Transcriptomic profiling of human peripheral blood-derived mast cells 9.72
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 9.72
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 9.72
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 9.65
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 9.62
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 9.59
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 9.56
EP400 is required for Max and MCPyV mediated gene activation 9.53
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 9.53
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 9.45
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 9.45
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 9.37
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 9.37
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 9.32
SLIGRL-induced gene expression changes in NHEK cells 9.32
miRNAs affected by antagomiR-17 treatment 9.24
SLAM-seq for K562 endogenous mRNA decay 9.21
Active translatome profiling with RiboLace in MCF7 cells 9.15
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 9.15
Novel Targeting of Transcription and Metabolism in Glioblastoma 9.14
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 9.1
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 9.1
p63 controls the enhancer landscape during keratinocyte differentiation 9.05
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 8.96
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 8.96
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 8.94
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 8.88
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 8.82
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 8.73
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 8.73
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 8.72
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 8.72
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 8.66
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 8.65
Survival of pancreatic cancer cells lacking KRAS function 8.63
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 8.58
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 8.52
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 8.49
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 8.49
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 8.43
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 8.39
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 8.38
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 8.36
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 8.35
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 8.35
The human blood-nerve barrier transcriptome 8.28
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 8.19
Noncoding regions are the main source of targetable tumor-specific antigens 8.18
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 8.17
TCF7L1 knockdown in pancreatic cancer 8.13
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 8.13
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 8.09
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 8.09
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 8.03
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 8.02
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 8.01
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 7.96
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 7.92
Human cell line and subcutaneous tumor 7.9
Gene expression in PANC1 cells treated with Rakicidin 7.86
Spliceosomal disruption of the non-canonical BAF complex in cancer 7.8
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 7.79
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 7.76
The pause-initiation limit restricts transcription activation in human cells 7.75
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 7.67
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 7.67
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 7.66
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 7.64
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 7.64
hTERT promotes cell adhesion and migration independent of telomerase activity 7.59
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 7.46
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 7.46
T47D RNA-seq and ChrRNA-seq data 7.45
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 7.45
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 7.33
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 7.32
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 7.32
RNA-seq analyses of human prostate cancer cells 7.31
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 7.29
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 7.28
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 7.21
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 7.2
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 7.18
ZIKV infection of monocytes activates inflammasome pathways 7.18
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 7.15
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 7.15
Transciptomic profiling of human fetal lung samples 7.11
Human HAP1 cells before and after nutrient deprivation 7.11
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 7.11
Effect of BMP inhibition or stimulation of primary human keratinocytes 7.1
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 7.1
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 7.1
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 7.1
RNA Seq of HMVEC under hypoxia 7.01
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 7.01
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 6.99
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 6.99
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 6.95
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 6.89
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 6.88
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 6.88
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 6.75
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 6.74
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 6.7
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 6.68
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 6.67
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 6.67
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 6.63
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 6.54
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 6.5
Hepatitis C virus functionally sequesters miR-122 6.5
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 6.48
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 6.36
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 6.36
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 6.32
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 6.28
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 6.27
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 6.26
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 6.26
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  6.22
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 6.19
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 6.17
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 6.17
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 6.14
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 6.11
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 6.08
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 6.03
RNAseq in Alzheimer's Disease patients 6.03
Overexpression and knockdown experiment for circCSNK1G3 6.01
Biological effect of chronic mistranslation in mammalian cells 5.92
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 5.87
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 5.84
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 5.84
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 5.82
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 5.82
Regulation of protein translation during mitosis 5.8
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 5.76
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 5.73
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 5.73
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 5.72
Differential gene expression profiles in imatinib-resistant cell lines 5.65
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 5.64
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 5.6
RNA-seq of RKO cells with cTAZ KO or putback 5.57
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 5.55
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 5.52
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 5.46
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 5.42
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 5.4
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 5.33
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 5.3
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 5.3
Small-molecule targeting of brachyury transcription factor addiction in chordoma 5.21
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 5.21
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 5.18
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 5.16
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 5.16
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 5.14
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 5.14
Comparative Analysis of Cas9 Activators Across Multiple Species 5.12
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 5.08
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 5.06
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 5.02
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 5.02
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 5.0
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 4.98
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 4.98
K562 polyA RNA-Seq 4.92
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 4.92
MicroRNA targetome analysis during HCMV infection 4.89
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 4.88
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 4.88
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 4.76
The transcriptome effect of overexpressing EZH2 in MCF7 4.76
AMPK signaling for naïve pluripotency [Hs] 4.71
AMPK signaling for naïve pluripotency 4.71
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 4.69
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 4.66
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 4.66
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 4.66
RNA-Seq of PRMT1 overexpression ECA109 cells 4.64
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.63
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 4.59
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 4.55
Transcriptional landscape changes during human embryonic stem cell derivation 4.52
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 4.51
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 4.49
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 4.46
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 4.44
CDK12 mediated transcriptional regulation in U2OS cells 4.38
Effect of from Human Umbilical Vein Endothelial Cells 4.35
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 4.34
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 4.3
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 4.13
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 4.12
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 4.1
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 4.07
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 3.99
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 3.96
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.93
Gene expression profile of human placenta from T. Cruzi infected mothers 3.93
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.91
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 3.86
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 3.85
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 3.85
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 3.75
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.75
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 3.73
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 3.72
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 3.72
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 3.71
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 3.71
The role of CFTR in islet function 3.71
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 3.65
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 3.62
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 3.56
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.53
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 3.39
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 3.35
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 3.35
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 3.31
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 3.27
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 3.26
Conservative alteration of chromosomal expression pattern across human solid tumor types 3.25
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 3.23
RNA-seq of MDA-MB-231 cells with TET1 knockout 3.23
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 3.22
IMP3 regulated gene expression in breast cancer cells 3.21
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 3.21
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 3.14
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 3.1
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 3.09
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 3.06
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 3.05
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 2.98
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 2.97
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.95
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 2.94
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 2.9
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 2.88
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 2.83
Defective structural RNA processing in relapsing-remitting multiple sclerosis 2.81
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 2.8
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 2.79
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 2.78
RNA Sequencing of Human iPS derived Cardiomyocytes 2.78
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 2.75
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 2.71
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.71
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 2.7
nELAVL HITS-CLIP in Alzheimer's Disease patients 2.69
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 2.56
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 2.54
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 2.54
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 2.53
NHLRC1 re-expression in cancer cells 2.53
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 2.51
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.5
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.5
Role of cervicovaginal microbiota in genital inflammation 2.47
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 2.44
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  2.44
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 2.44
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 2.43
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 2.37
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 2.34
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 2.2
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 2.2
mRNA recovered upon RNF219 IP. [RNA-IP] 2.2
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 2.2
A transcriptome dataset revealing the molecular features of breast cancer stem cells 2.18
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 2.17
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.17
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 2.15
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 2.13
Effect of BB608 on Gene Expression in HNSCC Cell Line 2.12
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 2.07
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 2.07
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.06
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 2.05
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.01
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 2.01
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.97
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.95
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 1.91
Measure transcript integrity using RNA-seq data 1.9
Transcriptome of U251 cells overexpression complement component 7 1.87
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.87
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.74
RNA-seq of cells with TET1 knockout 1.71
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 1.68
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 1.66
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 1.65
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 1.65
The transcriptome and chromatin accessbility landscape of mammalian germline 1.63
Gene expression regulated by CSA and CSB in neuroblastoma cell line 1.56
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 1.51
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 1.42
siRNA-mediated knockdown 1.41
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 1.38
Aneuploidy-induced cellular stresses limit autophagic degradation. 1.38
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.38
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 1.37
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.37
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.36
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.34
O-glcnAc reprograms cellular energetics 1.31
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.27
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.27
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.26
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.23
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 1.15
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 1.14
Finding missing proteins from epigenetically manipulated human cells 1.1
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.06
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.01
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.98
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.96
The cohesin complex prevents Myc-induced replication stress 0.93
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.9
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 0.88
HBEC-shp53-PCHD7 0.88
Identification of a LIF-responsive replication-competent human β cell 0.88
Expression profiling of MCF-7 cells with treatment of TCDD 0.87
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.87
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.85
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.85
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.85
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.74
Dilated cardiomyopathy vs Myocarditis 0.74
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 0.73
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.71
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 0.71
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 0.63
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 0.63
Function and hormonal regulation of GATA3 in human first trimester placentation 0.61
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.59
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 0.59
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.55
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.52
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.51
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.51
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.49
RNA-seq data 0.43
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.43
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.41
Gene expression changes due to PARP knockdown in human cells 0.38
Transcription elongation regulates genome 3D structure 0.38
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 0.33
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.31
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.31
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 0.29
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.29
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.28
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.26
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.26
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 0.24
Modulation of nonsense-mediated decay by rapamycin 0.12
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.1
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.1
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.09
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.08
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.08
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.08
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.08
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.08
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.07
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.07
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.06
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.06
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.05
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.05
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.04
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.04
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 0.04
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.03
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation